DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

GW Pharma Reports Submission Of Type II Variation Application To EMA To Expand Use Of EPIDYOLEX For Treatment Of Seizures Associated With Tuberous Sclerosis Complex

Benzinga · 03/13/2020 11:15